Ajantha E. Solomon

4.5k citations

44 papers · 3.9k · 2 hit papers · h-index 28

Impact in

Virology top 0.1%
- HIV Research and Treatment
Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 31
- HIV Research and Treatment 31
Infectious Diseases 14
- HIV/AIDS Research and Interventions 11
- HIV/AIDS drug development and treatment 11

Co-authors: Sharon Ruth Lewin (37 shared papers)Paul U. Cameron (26 shared papers)Fiona Wightman (10 shared papers)SARAH ELLEN PALMER (4 shared papers)Suzanne M. Crowe (6 shared papers)Suha M. Saleh (5 shared papers)Thomas A. Rasmussen (5 shared papers)Nicholas John Deacon (4 shared papers)
Journals: The Journal of Infectious Diseases (9 papers)AIDS (8 papers)Journal of Virology (4 papers)AIDS Research and Human Retroviruses (3 papers)The Journal of Immunology (3 papers)
Partner nations: Australia United States Canada

In The Last Decade

Ajantha E. Solomon

44 papers receiving 3.8k citations

Ajantha E. Solomon's Hit Papers

align trajectories log scale

Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy 2014 · 441 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2014 PLoS Pathogens
2014 The Lancet HIV

Peers

Countries citing papers authored by Ajantha E. Solomon

Since Specialization

Citations

This map shows the geographic impact of Ajantha E. Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajantha E. Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajantha E. Solomon more than expected).

Fields of papers citing papers by Ajantha E. Solomon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ajantha E. Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajantha E. Solomon. The network helps show where Ajantha E. Solomon may publish in the future.

Co-authors

The 25 scholars most cited alongside Ajantha E. Solomon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ajantha E. Solomon Line = papers co-authored together Ajantha E. Solomon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial The Lancet HIV ·Thomas A. Rasmussen, Martin Tolstrup, Christel R. Brinkmann, Rikke Olesen, Christian Erikstrup, Ajantha E. Solomon, Anni Assing Winckelmann, SARAH ELLEN PALMER Hit paper breakdown →	2014	535
2	Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy PLoS Pathogens ·Julian H. Elliott, Fiona Wightman, Ajantha E. Solomon, Khader Ghneim, Jeffrey D. Ahlers, Mark J. Cameron, Miranda Z. Smith, Tim D. Spelman Hit paper breakdown →	2014	441
3	The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo The Journal of Immunology ·Philip J. Ellery, Emma Tippett, Ya‐Lin Chiu, Geza Paukovics, Paul U. Cameron, Ajantha E. Solomon, Sharon Ruth Lewin, Paul R. Gorry	2007	288
4	Immunologic and Virologic Status after 14 to 18 Years of Infection with an Attenuated Strain of HIV-1 — A Report from the Sydney Blood Bank Cohort New England Journal of Medicine ·Jennifer C. Learmont, Andrew F. Geczy, JOHN S. MILLS, Lesley J. Ashton, Camille Helen Raynes-Greenow, Roger J Garsia, Wayne Bruce Dyer, Larissa B. McIntyre	1999	272
5	Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study The Lancet HIV ·Julian Elliott, James H. McMahon, Christina C. Chang, Sulggi A. Lee, Wendy Hartogensis, Namandjé N. Bumpus, Rada M. Savic, Janine Roney	2015	212
6	CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency Blood ·Suha M. Saleh, Ajantha E. Solomon, Fiona Wightman, Miranda Xhilaga, Paul U. Cameron, Sharon Ruth Lewin	2007	200
7	Establishment of HIV-1 latency in resting CD4 + T cells depends on chemokine-induced changes in the actin cytoskeleton Proceedings of the National Academy of Sciences ·Paul U. Cameron, Suha M. Saleh, Georgina B. Sallmann, Ajantha E. Solomon, Fiona Wightman, Vanessa A. Evans, Geneviève Boucher, Elias K. Haddad	2010	199
8	Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency AIDS ·Vanessa A. Evans, Renée M. van der Sluis, Ajantha E. Solomon, Ashanti Dantanarayana, Catriona M. McNeil, Roger J Garsia, SARAH ELLEN PALMER, Rémi Fromentin	2018	142
9	Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma AIDS ·Fiona Wightman, Ajantha E. Solomon, Sanjeev Srinivas Kumar, Nicolás Urriola, Kerri J. Gallagher, Bonnie M. Hiener, SARAH ELLEN PALMER, Catriona M. McNeil	2015	124
10	Inhibition of Telomerase Activity by Human Immunodeficiency Virus (HIV) Nucleos(t)ide Reverse Transcriptase Inhibitors: A Potential Factor Contributing to HIV-Associated Accelerated Aging The Journal of Infectious Diseases ·Edwin Leeansyah, Paul U. Cameron, Ajantha E. Solomon, Surekha Tennakoon, Pushparaj Velayudham, Maëlenn Gouillou, Tim D. Spelman, Anna C. Hearps	2013	114
11	Characterization of Three nef -Defective Human Immunodeficiency Virus Type 1 Strains Associated with Long-Term Nonprogression Journal of Virology ·David Ian Rhodes, Lesley J. Ashton, Ajantha E. Solomon, Andrew D Carr, David A. Cooper, John Martin Kaldor, Nicholas John Deacon	2000	113
12	Biological Determinants of Immune Reconstitution in HIV‐Infected Patients Receiving Antiretroviral Therapy: The Role of Interleukin 7 and Interleukin 7 Receptor α and Microbial Translocation The Journal of Infectious Diseases ·Reena Rajasuriar, David Richmond Booth, Ajantha E. Solomon, Kyra Yu Lin Chua, Tim D. Spelman, Maëlenn Gouillou, Timothy E. Schlub, Miles P. Davenport	2010	104
13	Both CD31+and CD31−Naive CD4+T Cells Are Persistent HIV Type 1–Infected Reservoirs in Individuals Receiving Antiretroviral Therapy The Journal of Infectious Diseases ·Fiona Wightman, Ajantha E. Solomon, Gabriela Khoury, Justin A. Green, Lachlan R. Gray, Paul R. Gorry, Yung Shwen Ho, Nitin K. Saksena	2010	96
14	An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine Journal of Virology ·David James Hooker, Gilda Tachedjian, Ajantha E. Solomon, Asitha D. Gurusinghe, Sally Land, Chris J. Birch, Jenny L. Anderson, Bidyut Roy	1996	95
15	Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus–Infected Individuals Receiving Suppressive Antiretroviral Therapy The Journal of Infectious Diseases ·Gabriela Khoury, Rémi Fromentin, Ajantha E. Solomon, Wendy Hartogensis, Marisela Killian, Hoh Rebecca, Ma Somsouk, Peter W. Hunt	2017	88
16	Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune Activation The Journal of Infectious Diseases ·Eileen P. Scully, Monica Gandhi, Rowena Johnston, Hoh Rebecca, Ainsley A. K. Lockhart, Dobrowolski Curtis, Amélie Pagliuzza, Jeffrey M. Milush	2018	81
17	Broad activation of latent HIV-1 in vivo Nature Communications ·Kirston Barton, Bonnie M. Hiener, Anni Assing Winckelmann, Thomas A. Rasmussen, Wei Shao, Karen Byth, Robert Lanfear, Ajantha E. Solomon	2016	65
18	Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells AIDS ·Fiona Wightman, Hao Kim Lu, Ajantha E. Solomon, Suha M. Saleh, Andrew Nicholas Harman, Anthony Lawrence Cunningham, Lachlan R. Gray, Melissa J. Churchill	2013	63
19	Coinfection of Hepatic Cell Lines with Human Immunodeficiency Virus and Hepatitis B Virus Leads to an Increase in Intracellular Hepatitis B Surface Antigen Journal of Virology ·David M. Iser, Nadia Warner, Peter A. Revill, Ajantha E. Solomon, Fiona Wightman, Suha M. Saleh, Megan Crane, Paul U. Cameron	2010	44
20	Dynamics of T Cells and TCR Excision Circles Differ After Treatment of Acute and Chronic HIV Infection The Journal of Immunology ·Sharon Ruth Lewin, Ruy Miguel Ribeiro, Gilbert R. Kaufmann, Don E. Smith, John J. Zaunders, Matthew G. Law, Ajantha E. Solomon, Paul U. Cameron	2002	44

About Ajantha E. Solomon

Ajantha E. Solomon is a scholar working on Virology, Infectious Diseases, Immunology, Epidemiology and Endocrine and Autonomic Systems, having authored 44 papers that have together received 3.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (31 papers), Immune Cell Function and Interaction (13 papers), HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (11 papers), T-cell and B-cell Immunology (6 papers), Cytomegalovirus and herpesvirus research (3 papers), Hepatitis B Virus Studies (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Virology (2.9k citations), Infectious Diseases (1.5k citations), Immunology (1.3k citations), Emergency Medicine (298 citations) and Epidemiology (662 citations). Ajantha E. Solomon has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Sharon Ruth Lewin, Paul U. Cameron, Fiona Wightman, SARAH ELLEN PALMER, Suzanne M. Crowe, Suha M. Saleh, Thomas A. Rasmussen, Nicholas John Deacon, Mathias D. Lichterfeld and Rikke Olesen. Their work appears in journals such as The Journal of Infectious Diseases, AIDS, Journal of Virology, AIDS Research and Human Retroviruses and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Ajantha E. Solomon

Impact in

Papers in i

In The Last Decade

Ajantha E. Solomon

Ajantha E. Solomon's Hit Papers

Peers

Countries citing papers authored by Ajantha E. Solomon

Fields of papers citing papers by Ajantha E. Solomon

All Works

About Ajantha E. Solomon

Explore authors with similar magnitude of impact

Papers in